Enroll in an online course today for flexible, self-paced learning—no fixed schedule required.
As psychiatry struggles to develop new, more effective treatments, clinical trials combining psychotherapy and the drug MDMA, also known as Ecstasy, are producing stunning results. New research suggests that incorporating psychedelics like MDMA and psilocybin into talk therapy can dramatically boost outcomes with an array of issues, including PTSD, anxiety, depression, relationship blocks, even drug addiction. If ongoing trials continue with favorable results, FDA approval for certified therapists to use MDMA- and psilocybin-assisted therapy in their practices could be on the horizon. Guided in this recording by the psychiatrist at the helm of the MDMA-assisted psychotherapy trials, you’ll explore:
This self-study program consists of 2.0 clock hours of continuing education instruction. Credit requirements and approvals vary by country and local regulatory bodies. Please save the course outline, the certificate of completion you receive from the activity and contact your local regulatory organization to determine specific eligibility and requirements.
| File type | File name | Number of pages | |
|---|---|---|---|
| Article 1 (970.2 KB) | 12 Pages | Available after Purchase | |
| Article 2 (404.9 KB) | 17 Pages | Available after Purchase | |
| Article 3 (96.9 KB) | 7 Pages | Available after Purchase | |
| Article 4 (864.8 KB) | 13 Pages | Available after Purchase | |
| Article 5 (378 KB) | 15 Pages | Available after Purchase | |
| Article 6 (409.5 KB) | 5 Pages | Available after Purchase | |
| Article 1 - French (970.2 KB) | 12 Pages | Available after Purchase | |
| Article 2 - French (404.9 KB) | 17 Pages | Available after Purchase | |
| Article 3 - French (96.9 KB) | 7 Pages | Available after Purchase | |
| Article 4 - French (864.8 KB) | 13 Pages | Available after Purchase | |
| Article 5 - French (378 KB) | 15 Pages | Available after Purchase | |
| Article 6 - French (409.5 KB) | 5 Pages | Available after Purchase | |
| Article 1 - Italian (970.2 KB) | 12 Pages | Available after Purchase | |
| Article 2 - Italian (404.9 KB) | 17 Pages | Available after Purchase | |
| Article 3 - Italian (96.9 KB) | 7 Pages | Available after Purchase | |
| Article 4 - Italian (864.8 KB) | 13 Pages | Available after Purchase | |
| Article 5 - Italian (378 KB) | 15 Pages | Available after Purchase | |
| Article 6 - Italian (409.5 KB) | 5 Pages | Available after Purchase | |
| Article 1 - German (970.2 KB) | 12 Pages | Available after Purchase | |
| Article 2 - German (404.9 KB) | 17 Pages | Available after Purchase | |
| Article 3 - German (96.9 KB) | 7 Pages | Available after Purchase | |
| Article 4 - German (864.8 KB) | 13 Pages | Available after Purchase | |
| Article 5 - German (378 KB) | 15 Pages | Available after Purchase | |
| Article 6 - German (409.5 KB) | 5 Pages | Available after Purchase | |
| Article 1 - Spanish (970.2 KB) | 12 Pages | Available after Purchase | |
| Article 2 - Spanish (404.9 KB) | 17 Pages | Available after Purchase | |
| Article 3 - Spanish (96.9 KB) | 7 Pages | Available after Purchase | |
| Article 4 - Spanish (864.8 KB) | 13 Pages | Available after Purchase | |
| Article 5 - Spanish (378 KB) | 15 Pages | Available after Purchase | |
| Article 6 - Spanish (409.5 KB) | 5 Pages | Available after Purchase |
Michael Mithoefer, MD, is clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.
Speaker Disclosures:
Access never expires for this product.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to info@pesi.eu.
Please wait ...